A mechanism for improved talc pleurodesis via foam delivery

Drug Deliv. 2021 Dec;28(1):733-740. doi: 10.1080/10717544.2021.1895910.

Abstract

Talcum powder is recognized as the leading drug for pleurodesis, a treatment of choice for malignant pleural effusions. Recently, it was shown that hydrogel foam delivery systems significantly enhanced the number of adhesions between the chest wall and the lung in a New Zealand rabbit model due to the sol-gel transition. However, many questions still remain regarding the cause of improved efficacy, such as: (1) Would only hydrogel foams improve the efficacy of talc pleurodesis? (2) Is it possible to achieve the same efficacy of hydrogels using non-hydrogel foams? 3) What are the physicochemical properties that can be correlated to the efficacy of talc pleurodesis? In this study, we use non-hydrogel foam formulations to determine the efficacy of pleurodesis. Foam stability and rheology of the formulations were correlated to adhesion formation. The results clearly suggest a correlation of pleurodesis efficacy to the viscosity and modulus of the foam delivery system.

Keywords: Drug delivery; foam; malignant pleural effusions; pleurodesis; rheology.

MeSH terms

  • Animals
  • Chemistry, Pharmaceutical
  • Drug Stability
  • Hydrogels / chemistry*
  • Pleurodesis / methods*
  • Rabbits
  • Rheology
  • Talc / administration & dosage*
  • Talc / therapeutic use

Substances

  • Hydrogels
  • Talc